카발레타바이오(주)
US ˙ NasdaqGS ˙ US12674W1099

SecurityCABA / Cabaletta Bio, Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership5,130,763 shares
Ownership 5.30%
Millennium Management Llc ownership in CABA / Cabaletta Bio, Inc.

2026-02-18 - Millennium Management Llc has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,130,763 shares of Cabaletta Bio, Inc. (US:CABA). This represents 5.3 percent ownership of the company.

Millennium Management Llc has a history of taking positions in derivatives of the underlying security (CABA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2026-02-18 2026-02-18 13G 5,130,763 5.30

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CABA / Cabaletta Bio, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CABALETTA BIO COM 12674W109 5,903,281 3,166,369 115.69 15,880 164.96 0.0066
2026-02-17 2025-12-31 13F CABALETTA BIO COM 12674W109 2,736,912 2,050,099 298.49 5,994 272.93 0.0025
2025-11-14 2025-09-30 13F CABALETTA BIO COM 12674W109 686,813 -168,517 -19.70 1,607 23.62 0.0007
2025-08-14 2025-06-30 13F CABALETTA BIO COM 12674W109 855,330 686,431 406.42 1,300 457.94 0.0006
2025-05-15 2025-03-31 13F CABALETTA BIO COM 12674W109 168,899 -342,714 -66.99 234 -79.93 0.0001
2025-02-14 2024-12-31 13F CABALETTA BIO COM 12674W109 511,613 -1,117,300 -68.59 1,161 -84.90 0.0006
2024-11-14 2024-09-30 13F CABALETTA BIO COM 12674W109 1,628,913 930,596 133.26 7,688 47.20 0.0036
2024-08-14 2024-06-30 13F CABALETTA BIO COM 12674W109 698,317 238,950 52.02 5,223 -33.35 0.0024
2024-05-15 2024-03-31 13F CABALETTA BIO COM 12674W109 459,367 459,367 7,837 0.0033
2023-11-14 2023-09-30 13F CABALETTA BIO COM 12674W109 0 -371,070 -100.00 0 -100.00
2023-08-14 2023-06-30 13F CABALETTA BIO COM 12674W109 371,070 -201,049 -35.14 4,791 1.25 0.0024
2023-05-15 2023-03-31 13F CABALETTA BIO COM 12674W109 572,119 220,994 62.94 4,731 45.66 0.0027
2023-02-14 2022-12-31 13F CABALETTA BIO COM 12674W109 351,125 120,572 52.30 3,248 2,065.33 0.0018
2022-11-14 2022-09-30 13F CABALETTA BIO COM 12674W109 230,553 -7,683 -3.22 150 -40.71 0.0001
2022-08-15 2022-06-30 13F CABALETTA BIO COM 12674W109 238,236 -122,765 -34.01 253 -65.48 0.0002
2022-05-16 2022-03-31 13F CABALETTA BIO COM 12674W109 361,001 218,864 153.98 733 35.99 0.0004
2022-02-14 2021-12-31 13F CABALETTA BIO COM 12674W109 142,137 20,513 16.87 539 -63.56 0.0003
2021-11-15 2021-09-30 13F CABALETTA BIO COM 12674W109 121,624 -868,706 -87.72 1,479 -82.63 0.0009
2021-08-16 2021-06-30 13F CABALETTA BIO COM 12674W109 990,330 114,417 13.06 8,517 -12.40 0.0052
2021-05-17 2021-03-31 13F CABALETTA BIO COM 12674W109 875,913 270,668 44.72 9,723 28.73 0.0070
2021-02-16 2020-12-31 13F CABALETTA BIO COM 12674W109 605,245 3,415 0.57 7,553 15.77 0.0055
2020-11-16 2020-09-30 13F CABALETTA BIO COM 12674W109 601,830 -30,074 -4.76 6,524 -7.32 0.0080
2020-08-14 2020-06-30 13F CABALETTA BIO COM 12674W109 631,904 239,089 60.87 7,039 145.43 0.0096
2020-05-14 2020-03-31 13F CABALETTA BIO COM 12674W109 392,815 152,865 63.71 2,868 -14.44 0.0064
2020-02-14 2019-12-31 13F CABALETTA BIO COM 12674W109 239,950 239,950 3,352 0.0042
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-02-14 2024-12-31 13F CABALETTA BIO COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F CABALETTA BIO COM Call 100,000 472 n/a n/a n/a
2024-08-14 2024-06-30 13F CABALETTA BIO COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F CABALETTA BIO COM Call 100,000 1,706 n/a n/a n/a
2021-08-16 2021-06-30 13F CABALETTA BIO COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-17 2021-03-31 13F CABALETTA BIO COM Call 55,000 611 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-08-16 2021-06-30 13F CABALETTA BIO COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-17 2021-03-31 13F CABALETTA BIO COM Put 50,000 555 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.